Physician profile
Lawrence Geller
NPI 1730101189
$2,758.29
in general payments reported to CMS, 2019-2025
20 companies · $736 in 2025
The $736 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $330 · 2021: $430 · 2022: $180 · 2023: $171 · 2024: $452 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $642.46 | 2021-2025 | Interstim, Altaviva |
| Neotract INC. | $302.37 | 2019-2020 | |
| Procept Biorobotics Corporation | $288.66 | 2021 | |
| Teleflex LLC | $274.29 | 2022-2025 | Urolift, Barrigel |
| Medtronic USA, INC. | $259.31 | 2019-2020 | |
| Boston Scientific Corporation | $185.19 | 2022-2025 | Moses 550 Dfl, Axonics |
| Calyxo, INC. | $156.49 | 2025 | Cvac Aspiration System |
| Coloplast Corp | $138.35 | 2019-2025 | |
| Caldera Medical, INC | $107.54 | 2025 | |
| Astellas Pharma US INC | $73.33 | 2019 | |
| Abbvie INC. | $65.77 | 2022-2025 | |
| Axonics, INC. | $59.06 | 2024 | Axonics, Bulkamid |
| Laborie Medical Technologies Corp. | $43.97 | 2024-2025 | Endosheath Technology |
| 180 Medical, INC. | $40.67 | 2019-2023 | Gentlecath Glide |
| Tolmar Pharmaceuticals, INC. | $29.14 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.17 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $18.66 | 2023 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $17.41 | 2024 | |
| Myovant Sciences INC. | $15.99 | 2022 | |
| Tolmar, INC. | $15.46 | 2025 | Eligard, Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Geller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.